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PENSTERILAN SISA PEPEJAL KLINIKAL MENGUNAKAN CECAIR 
KARBON DIOKSIDA LAMPAU GENTING 
  
ABSTRAK 
Satu kajian awal mengenai amalan pengurusan sisa klinikal telah dijalankan di Hospital 
Lam Wah Ee, Pulau Pinang, Malaysia. Amalan pengurusan merangkumi pengasingan, 
pengumpulan, pengangkutan dan memerlukan pelaburan kewangan yang tinggi. 
Walaupun amalan ini dipraktikkan, namun risiko jangkitan masih wujud. Program kitar 
semula didapati tidak mengurangkan jumlah sisa pepejal klinikal, bahaya dan kos 
pelupusan. Dalam kajian ini, beberapa jenis bakteria patogenik nosocomial dan 
oportunis telah dikenal pasti dan pensterilan sisa pepejal klinikal adalah perlu untuk 
mengurangkan risiko jangkitan kepada pekerja. Perbandingan kecekapan sterilisasi 
autoklaf wap dan karbon dioksida superkritikal (SF-CO2) pada sisa pepejal klinikal telah 
dijalankan. Penyahaktifan bakteria melalui kaedah pensterilan wap bergantung kepada 
suhu (121 
0
C), masa rawatan (60 minit) dan jenis spesies bakteria. SF-CO2 berupaya 
menyahaktif hampir kesemua spesies bakteria termasuk E. coli, E. faecalis, S. 
marcescens dan S. aureus, B. sphaericus pada suhu yang agak rendah iaitu 60
0
C dan 
tekanan sederhana pada 20 MPa. Model matematik Gompertz telah digunakan untuk 
menggambarkan tingkah laku penyahaktifan bakteria dalam sisa klinikal dengan 
menggunakan keadah SF-CO2. Pertumbuhan semula bakteria tidak berlaku dalam sisa 
yang telah dirawat dengan kaedah SF-CO2. Sisa rawatan sterilisasi autoklaf 
menunjukkan pertumbuhan semula bakteria selepas 2 hari. Analisa Mikroskop Elektron 
Pengskanan (SEM), protein selular dan aktiviti enzim yang belum dirawat, dirawat 
dengan autoklaf dan dirawat dengan SF-CO2 mendedahkan bahawa autoklaf wap 
xxv 
 
menyahaktifkan bakteria secara fizikal dan mengubah sifat enzim selular. Dalam 
rawatan SF-CO2 tekanan menjadi faktor yang menyebabkan kerosakan pada dinding sel, 
perpecahan sel dan anjakan pada bahagian luar membran. Ketiadaan protein semasa 
analisis SDS-PAGE mencadangkan bahawa protein selular dan enzim telah terlarut 
dalam SF-CO2. Keputusan keseluruhan kajian ini menunjukkan bahawa teknik 
pensterilan sisa pepejal klinikal SF-CO2 adalah lebih berkesan untuk digunakan dalam 
pengurusan sisa klinikal, terbukti berupaya mengurangkan risiko pendedahan kepada 
jangkitan dan keupayaan untuk memusnahkan sel-sel bakteria secara kimia dan fizikal. 
Dengan pengurangan risko, pihak hospital secara tidak langsung dapat menyediakan 
persekitaran yang selamat bagi pesakit, penjagaan kesihatan dan kakitangan klinikal. 
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SUPERCRITICAL FLUID CARBON DIOXIDE STERILIZATION OF 
CLINICAL SOLID WASTE 
 
ABSTRACT 
There is growing awareness on safe handling and management of clinical solid waste.  
The aim of the present study was to determine an effective sterilization method for safe 
handling and recycle-reuse of clinical solid waste materials. A preliminary study on the 
clinical waste management practice was conducted at Hospital Lam Wah Ee, Penang, 
Malaysia. The management practices encompasses segregation, collection, 
transportation and require high financial investments. Despite these practices, the 
infectious risk is still at hand. The existing recycling programs of general solid waste 
materials remains unchanged of the amount of clinical solid waste generation, its hazard 
and the disposal cost. In this study, several types of nosocomial and opportunistic 
pathogenic bacteria have been identified and sterilization of clinical solid waste is 
requisite to minimize infectious risks to the workers. Comparison on the sterilization 
efficiency of steam autoclave and supercritical carbon dioxide (SF-CO2) on clinical solid 
waste was conducted. Steam sterilization inactivation of bacteria depended on 
temperature and treatment time and types of bacterial species. The most effective 
experimental condition for the autoclave treatment was found to be temperature 121 
0
C 
and 131 
0
C for the exposure time 60 min and 30 min, respectively. SF-CO2 inactivates 
the bacteria in clinical solid waste including E. coli, E. faecalis, S. marcescens and S. 
aureus, B. sphaericus at a relatively lower temperature at 60 
0
C and  moderate  pressure  
of 20 MPa. Gompertz mathematical model was used to describe the inactivation 
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behavior of bacteria in clinical solid waste using SF-CO2. No re-growth of bacteria was 
detected in SF-CO2 treated wastes, unlike bacterial re-growth in autoclave treated waste 
in 2 days. Analysis of Scanning Electron Microscope (SEM), cellular protein and 
enzymatic activity of bacterial cells revealed that steam autoclave physically inactivates 
the bacteria and denatures cellular enzymes. Meanwhile, SF-CO2 inactivates the bacteria 
both physically and chemically. Both Pressure and temperature were the factors that 
cause cell wall damage and extracted out the cytoplasmic materials of bacterial cell.   
The absence of proteins and enzymes in the SDS-PAGE and APIZYM analysis, 
respectively, suggests that the cellular protein and enzymes have been dissolved in the 
SF-CO2. The overall results of this study suggest that SF-CO2 sterilization of clinical 
solid waste is a more effective technique to be employed in the clinical waste 
management. SF-CO2 was proven to have reduced the risk of exposure to infection 
based on its capability to destroy the bacteria cells. With the reduced risk, the hospital 
could provide a safer environment for patients, healthcare and clinical staffs. 
 
 
1 
 
Chapter One: Introduction 
 
 
1.1 Clinical solid waste management in Malaysia 
 
In the last few decades, human activities and changes associated with lifestyles 
and consumption patterns have resulted in the generation of huge volumes of different 
types of wastes. The wastes have threatened the survival of humans and other living 
things, as well as the natural resources, those are necessary for human existence. 
Consequently, in little more than two decades public concern over the waste 
management and the pollution problems associated with waste generation have attracted 
significant attention and a great deal of researches have been conducted to evaluate 
appropriate waste management options in order to minimize environmental pollution 
and maximize resource recovery (Williams, 2005). In recent years, concern over the 
solid waste from healthcare facilities (HCFs) has increased throughout the world 
(DenBos and Izadpanah, 2002). Clinical solid waste, arising principally from hospitals 
and clinics, is potentially dangerous since it can spread infectious diseases due to the 
inadequate management of clinical solid waste (Abd El-Salam, 2010; Al-Khatib and 
Sato, 2009).  
 
 
There is growing awareness on effective control and safe handling of clinical 
solid waste in worldwide due to the common concern for hospital hygiene (Alagoz and 
Kocasoy, 2008; Bdour et al., 2007). Clinical solid waste is prescribed by many as 
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infectious, requires pertain approach during handling and disposal of clinical solid waste 
(Abd El-Salam, 2010). The amount of clinical solid waste generation increases 
significantly in Malaysia with increasing public healthcare facility and advance 
technology (Tabasi and Marthandan, 2013). The existing clinical waste management 
practice in Malaysia is not able to adequately preserve human health and environmental 
contamination. The Ministry of Health (MOH, 2009) reported that the most common 
issue for the inadequate clinical solid waste management practice in Malaysia is the 
improper waste segregation at source. General waste is mixing with clinical solid waste 
and vice versa due to improper segregation practices in hospitals (DOE, 2009).  
 
 
The increasing treatment and disposal cost of clinical solid waste and its hazards 
to human health and environment are relating to the miss classification, improper 
segregation of the waste (Blenkharn, 2005; Diaz et al., 2008; Lee et al., 2004). The 
technologies used at present to dispose the clinical solid waste is not environmentally 
friendly and do not cope with clinical solid waste in a safe manner. For example, the 
most used technology to dispose clinical solid is incineration. The incineration is 
considered as an inappropriate technology for treating clinical solid waste  due to release 
a wide variety of pollutants including dioxins, furans, heavy metals, acid gases, carbon 
monoxide, and nitrogen oxide (Coker et al., 2009; Lee et al., 2004; Singh et al., 2011). 
Moreover, the incineration technology requires high financial start-up cost and 
occupational capital to implement the facilities (Alagöz & Kocasoy, 2008; Lee et al., 
2004).  
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Recycling-reuse of clinical solid waste materials is the most desirable way to 
reduce the waste generation and to prevent materials from entering the waste stream 
(Lee et al., 2004; Tsakona et al., 2007). Clinical solid waste contains enormous volumes 
of recyclable materials (Lee et al., 2004; Marinkovic et al., 2008). Therefore, the 
development of recycling clinical solid waste can serve as a means of reducing rising 
quantities of waste generation and its treatment cost (Blekharn, 2005; Jang et al., 2006; 
Lee et al., 2004; Ozbek and Sanin, 2004; Park and Jeong, 2001; Patil and Shekdar, 2001; 
Tsakona et al., 2007; Tudor, 2007). Clinical solid waste must be free from infectious 
agents prior to recycling the waste materials.  On this basis, the clinical solid waste must 
be sterilized at the point of generation in order to avoid possible infectious threat of 
clinical solid waste (Marinkovic et al., 2008; Tsakona et al., 2007). 
 
 
The definition of the term ‘sterilization’ is the complete destruction or removal 
of all living microorganisms on or within a substance, including bacteria or spores, 
viruses, and fungi (Maurer, 1978; Williams, 2005; Zhang et al., 2006a). Sterilization of 
clinical solid waste presents a challenge to current sterilization technology due to the 
major portions of clinical solid waste are heat sensitive plastic or polymer materials. In 
medical practice, the most common sterilization techniques used are stream autoclaving, 
ethylene oxide, and gamma-radiation (Dempsey and Thirucote, 1989; Zhang et al., 
2006a). Though, all these methods assure a satisfactory microbial inactivation, but still 
exists a number of limitations (Nik Norulaini et al., 2008; Spilimbergo et al., 2003). 
Steam autoclave, despite inactivate the microorganisms, can destroy the temperature 
sensitive materials (White et al., 2006). Additionally, the steam sterilization technique is 
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expensive and difficult to control because of the extremely high temperature required 
(Spilimbergo et al., 2002, 2003; White et al., 2006). Gama–radiation sterilization may 
change tensile strength and transparency of reusable waste material (Dillow et al., 1999). 
Ethylene oxide, on the other hand, is a toxic and flammable gas. It is a known 
carcinogen and can cause hemolysis (Dillow et al., 1999). Ethylene oxide sterilization 
can also chemically destroy the polymer materials.  Hence, the available sterilization 
technologies in medical care are not suitable for the sterilization of clinical solid waste, 
since the heat sensitive recyclable and reusable clinical solid waste materials may 
destroy either thermally or chemically. Because of the limitation of the current 
sterilization technology, a low temperature sterilization technology must be evaluated to 
deal with clinical solid waste in order to propose cost effective and safer clinical solid 
waste management practice (Marinkovic et al., 2008). 
 
 
Supercritical fluid carbon dioxide (SF-CO2) is an effective sterilization method 
that has notable benefits over the existing sterilization method. The fluid carbon dioxide 
at the supercritical state (31.1 °C, 7.4 MPa) is non-toxic and nonflammable. Carbon 
dioxide is easily available as an industrial byproduct and thus is inexpensive. SF-CO2 is 
proven to be effective against any sort of microorganisms, as it impacts target 
microorganisms both physically and chemically (Jimenez et al., 2008; Kim et al., 2009; 
Spilimbergo et al., 2002). SF-CO2 has been potentially used to sterilize biomedical 
device for being effective against bacteria (Dillow et al., 1999; Spilimbergo et al., 2002), 
viruses (Fages et al., 1998), and spores (Zhang et al., 2006b). This technology sterilizes 
the heat sensitive biomedical device without any damage and lowering its quality 
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(Dillow et al., 1999; Zhang et al., 2006a). Although, SF-CO2 has been proven as an 
effective sterilization technology, limited researches have been conducted to sterilize the 
clinical solid waste using SF-CO2. Thus, the adoption of SF-CO2 sterilization technology 
in clinical solid waste management is receiving potential interest with regards to 
determine a safer and resource recovery clinical solid waste management practice.  
 
 
1.2 Problem statement  
 
Many studies have documented to determine a safer clinical waste management 
practice within an affordable cost by the healthcare facilities. Patwary et al. (2009a) 
reported that segregation of general waste could dramatically impact on lowering the 
clinical waste generation. Studies conducted by Lee et al. (2004) and Tudor et al. (2007) 
reported that the recycling of healthcare waste is a good solution as a means of  reducing 
rising quantities of clinical solid waste and its treatment cost. Lee et al. (2004) further 
reported that it must ensure that the recyclable healthcare waste must be free from 
infectious agent prior to conducted recycling program. Although, segregation practice 
would protect the mixing of general solid waste with the infectious waste, how it could 
affect the clinical solid waste generation rate and the treatment cost is not well described 
in literature. Most of the developing country's hospitals are facing financial constrain, 
lack of regulatory guideline in country level, inadequate segregation materials and 
trained clinical staffs, those are crucial to conduct effective segregation, resource 
recovery and recycling program of healthcare solid waste (Ozbek and Sanin, 2004; 
Sabour et al., 2007; Shinee et al., 2008 ). Therefore, effective source segregation and 
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recycling practice of healthcare solid waste in a safe manner is impossible for most of 
the HCFs of developing countries.  
 
 
One of the major reasons of improper clinical solid waste management practice 
in a healthcare facility is that the healthcare worker are not aware of possible infectious 
risk of clinical solid waste (Alagoz and Kocasoy, 2008; Coker et al., 2009; Saini et al., 
2004). There is limited scientific information available in literature on the role clinical 
waste as a reservoir of infectious diseases. It is obligatory to characterize the types of 
microorganisms present in clinical solid waste in order to achieve a reliable infectious 
risk of the clinical solid waste.  
 
 
Available technologies (i.e., incineration, Autoclave, microwave) used to treat 
clinical solid waste are not environmentally friendly and not able to preserve human 
health and the environment (Alagoz and Kocasoy, 2008, Marinkovic et al., 2008). 
Marinkovic et al., (2008) declared that sterilization using a mobile device at its source is 
the most acceptable solution to infectious medical waste (infectious waste and sharp 
objects). Sawalem et al., (2009) suggested adopting a low operating cost, easily 
implementable, and low maintenance sterilization method in clinical waste management 
to prevent contamination. Sterilization of the clinical solid waste with the view of 
conducting resource recovery is challenging due to major portions of clinical solid waste 
materials are made of heat sensitive plastics or bio-polymers. However, numerous 
studies reported that SF-CO2 is a gentle terminal sterilization technology, which could 
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sterilize the heat sensitive high density plastics and polymers without damage and 
lowering the quality (Dillow et al., 1999; Ellis et al., 2010; White et al., 2006, Zhang et 
al., 2006a). No study has been conducted yet to determine the acceptable sterilization 
technology to sterilization clinical waste at its generation source. It is therefore, bearing 
considerable concern to determine a reliable sterilization technology to handle the 
clinical solid waste in a safe manner.  
 
 
Many studies have been carried out to inactivate the bacteria in environmental 
waste using various sterilization technologies. Little attention has been paid on the re-
growth bacteria from the sterilized waste. Bacteria are cellular microorganisms, able to 
re-grow and multiply under a favorable nutrient requirement (Chong et al., 2010; Rusin 
et al., 1997). Therefore, it must be ensured the complete inactivation of the bacteria in 
the cellular level in order to avoid unexpected re-growth of bacteria prior to decide any 
sterilization technology. Studies reported that pressure, temperature and medium are 
substantial during inactivation of bacteria in the SF-CO2 treatment (Dillow et al., 1999; 
Kim et al., 2009; Spilimbergo et al., 2003), but there is not yet clear understanding of 
this effect. Several hypotheses have been proposed as an inactivation mechanism 
including cell rupture, lipid modification, changes of protein, loss of enzymatic 
activities, acidification, etc., (Dillow et al., 1999; Lin et al., 2008; Spilimbergo and 
Bertucco, 2003). However, there is limited evidence available in literature to acquire 
clear understating and confirm the proposed mechanisms.  
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1.3 Objectives 
 
The objectives are: 
 
1. To determine the current status of clinical waste management practice in a 
hospital of Penang, Malaysia. 
2. To identify the bacteria in clinical solid waste, sharp waste and general solid 
waste. 
3. To determine the effectiveness of the SF-CO2 sterilization on the inactivation of 
microorganisms in clinical solid waste.  
4. To study the inactivation mechanisms of bacteria in clinical solid waste and the 
re-growth of bacteria in sterilized clinical solid waste. 
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Chapter Two: Literature Review 
  
 
2.1 Clinical Solid Waste Management 
 
 Safe Clinical solid waste management is crucial due to avoid the potential 
hazards to human health and environmental. Clinical solid waste is perceived by many 
as hazardous or infectious (Blenkharn, 1995; Miyazaki and Une, 2005; Phillips, 1999; 
Salkin, 2003). Although surveys refer that about 10-25% of waste contains the infectious 
agent (Bendjoudi et al., 2009; Mohee, 2005; Shinee et al., 2008), but Saini et al. (2004) 
reported that general waste may contain pathogenic bacteria and the microbial flora 
present in clinical waste and general waste might similar. Besides, there is a possibility 
of the contamination of non-clinical waste (general waste) with infectious agents during 
poor segregation, collection, storage and transportation (Blenkharn, 1995; Shinee et al., 
2008). Hence, effective attention must be placed during treating clinical solid waste so 
that clinical waste cannot mix with non-clinical waste. Accordingly, clinical solid waste 
should be handled, stored, transported and disposed of in a controlled manner to 
safeguard public health and to prevent environmental pollution. Infectious pathogenic 
microorganisms may infect the human body during unsafe handling via direct contact 
(puncture, abrasion or cut in the skin) or indirect conduct (mucous membranes, 
inhalation or ingestion) (Pruss et al., 1999). A particular concern on the handling of 
sharps clinical solid waste, it represents the most acute potential hazards to health 
(Alagoz and Kocasoy, 2008). The management of clinical solid waste, particularly in 
developing countries is often poor and fraught with difficulties.  
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Unless clinical waste is properly handled and disposed, it can present risks to 
healthcare staffs, the public and the environment (Al-Khatib and Sato, 2009; Shinee et 
al., 2008). There is not yet clear understanding of the infectious risk of the inadequate 
clinical solid waste management, which is often implemented. A Number of studies 
have been conducted in many countries to define the best appropriate clinical waste 
management plan in order to minimize the health hazards and associate environmental 
pollution (Alagoz and Kocasoy, 2008; Bdour et al., 2009; Bendjoudi et al., 2009; Cheng 
et al., 2009; Da Silva et al., 2005; Hassan et al., 2008; Sawalem et al., 2009; Shinee et 
al., 2008). All such studies have indicated that the planning and implementation of waste 
management practices would reduce waste generation, minimize health hazard and 
disposal cost.  
 
 
The management of clinical solid waste is considered as problematic due to its 
enormous volume of generation, serious threat to the human health as well as disposal 
cost (Bendjoudi et al., 2009; Da Silva et al., 2005; Diaz et al., 2008; Jang et al., 2006; 
Saini et al., 2004). Many developed countries have devised codes of practices and 
guidelines for handling and disposal such waste (Bdour et al., 2007; Da Silva et al., 
2005; Lee et al., 2004). Although significant progress has been found, yet it still requires 
further modification in all aspects of clinical waste management practices. In most 
developing countries, clinical  waste has not received adequate attention despite the fact 
that clinical waste labeled as hazardous or infectious (Alagoz and Kocasoy, 2008; Coad, 
1992; Da Silva et al., 2005; Jang et al., 2006; Tsakona et al., 2007). In developing 
countries, clinical solid waste has been handled and disposed together with the non-
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clinical waste, which is creating inevitable risks to the health care workers, publics and 
the environment (Alagoz and Kocasoy, 2008; Bendjoudi et al., 2009; Da Silva et al., 
2005; Marinkovic et al., 2008; Shinee et al., 2008). WHO in 2002 conducted an 
investigation survey on the clinical waste management in 22 developed countries. The 
survey reported that the proportion of healthcare facilities that do not use proper waste 
disposal methods ranges from 18-64% (WHO, 2004). Healthcare workers are not 
educated and most of them have not had any special training on the clinical waste 
management (Coker et al., 2009; Diaz et al., 2008; Shinee et al., 2008).  Generally, they 
use two hands during collection and sorting the waste (Shinee et al., 2008). Most of the 
healthcare institutions do not have appropriate color coded bags or containers for sorting 
the waste (Alagoz and Kocasoy, 2008). Some of the healthcare facilities have used 
plastic bags, paper bags or cardboard boxed to collect the clinical solid waste (Coker et 
al., 2009; Shinee et al., 2008). Besides, healthcare waste is not sorted because of the high 
fee of their disposal cost, therefore both clinical and non-clinical waste are mixed 
together and dump illegally (Alagoz and Kocasoy, 2008; Coker et al., 2009; Shinee et 
al., 2008). Even most of the hospitals have not any special place for the storage the 
clinical waste prior to disposal.  Clinical waste is placed in an unsecured area until 
collected and it is fully accessible to the animals (Alagoz and Kocasoy, 2008; Da Silva 
et al., 2005).  
 
 
World Health Organization defined an effective clinical solid waste management 
in a clinical facility depends on dedicated waste management plan, good administration, 
adequate financing and participation by trained clinical staff (WHO 2005),. In addition, 
12 
 
clear definition and classification of the waste (Askarian et al., 2004; Shinee et al., 
2008), source segregation of the waste (Moreira and Gunther, 2013), the estimation of 
the amount and type of waste generated (Tsakona et al., 2007), and the use of 
appropriate disposal technology (Lee et al., 2004; Diaz et al., 2008) are crucial in order 
to decide an effective clinical solid waste management. 
 
 
2.2 Definition and classification of Clinical solid waste 
 
The waste generated in Healthcare facilities (HCFs) has not clearly been defined 
in the literature. There are currently several terms used to describe the waste that is 
generated in healthcare facilities, as presented in Table 2.1. It can lead to problems as it 
is important to have a specific definition of those wastes derived from healthcare 
premises. This is because, there are practical considerations to differentiate between the 
waste and the waste from HCFs, and in relation to choosing a right waste disposal 
method, which depends on the clear understanding (Bendjoudi et al., 2009; Moritz, 
1995; Nemathaga et al., 2008). In literature, the terms ‘clinical waste’, ‘health care 
waste’, ‘infectious waste’ and ‘medical/hospital waste’ are typically encountered, they 
may have similar meanings or be subsets of one another, which substantially inhibits 
using and comparing data from different countries (Bendjoudi et al., 2009; Diaz et al., 
2008; Jang et al., 2006; Lee et al. 2002; Mato and Kaseva, 1999; Moritz, 1995; 
Nemathaga et al., 2008).  
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Table 2.1 Definitions and general classification of waste arising from healthcare 
 facilities. 
  
Definition Classification Reference 
Health care waste General waste and medical Waste Shinee et al., 2008 
Hospital waste General waste, medical waste and 
sharp 
Nemathaga et al., 2008 
Medical waste Infectious waste and general medical 
waste 
Cheng et al., 2009 
Medical waste General waste and special waste Lee et at., 2004 
- Infectious waste and non-infectious 
waste 
Miyazaki and Une, 
2005 
Hospital waste General waste and Hazardous waste Sawalem et al., 2009 
Healthcare waste Hazardous and non-hazardous waste Mohamed et al., 2009 
Medical waste Domestic waste and hazardous waste Abd El-Salam, 2010 
Hospital waste Hazardous and non-hazardous waste Kaisar Alam Sarkar, et 
al., 2006 
Healthcare waste Medical waste and general waste Ruoyan et al., 2010 
Medical/Hospital 
waste 
Infectious and municipal waste Tsakona et al., 2007 
Medical waste Tissues and other Jang et al., 2006 
Medical waste Hazardous and non-hazardous waste Patwary et al., 2009a 
 
 
Lee et al., (2002) used the term medical waste to deal with all types of wastes 
produced by HCFs. It includes all types of waste generated by HCFs, such as hospitals, 
clinics, physician office and other medical laboratory and research facilities (Hall, 1989; 
Jang et al., 2006). Medical waste is a subcategory of healthcare waste, which potentially 
indicates the infectious waste except sharps (Lee et al., 2002). Nemathaga et al. (2008) 
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delineated the definition of hospital waste is any type of waste generated from healthcare 
facilities. This includes both non-clinical and clinical waste constituents. The World 
Health Organization refers to the waste generate from HCFs as healthcare waste (HCW). 
According to Bendjoudi et al. (2009), HCW results from the treatment, diagnosis, or 
immunization of humans and/or animals in hospitals, veterinary and health-related 
research facilities, and medical laboratories. This type of waste contains infectious 
waste, toxic chemicals and heavy metals, and may contain substances that are genotoxic 
or radioactive. Generally, a small portion of the total healthcare waste bears the 
infectious agent. Clearly, 10-25% of total healthcare wastes are infectious (Bendjoudi et 
al., 2009; Mohee, 2005; Pruss et al., 1999), therefore waste arising from HCFs cannot be 
defined as infectious waste. Besides, all waste cannot be addressed as clinical waste. 
There are some categories of waste, those are not falling within the definition of clinical 
waste (Moritz, 1995).  
 
 
Healthcare waste can be classified as non-clinical waste (non regulated HCW, 
also can define as general waste), and clinical waste (special waste, regulated HCW) 
(Lee et al., 2002, 2004; Mato and Kassenga, 1997). Non-clinical waste is such type of 
waste, which is not posing any infectious risk to human health and environment. 
Examples of non-clinical waste include packaging materials such as cardboard, office 
paper, leftover food, cans etc. (Lee et al., 2002, 2004; Diaz et al., 2008; Pruss et al., 
1999). Conversely, clinical solid waste is the type of solid waste materials, which 
generates in clinical facilities during diagnosis, treatment, immunization, in research 
pertaining thereto and biological testing (WHO, 2000, 2004). Examples of clinical solid 
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waste are discarded surgical gloves, glassware, instruments, needles, lancets, culture, 
stocks and swabs and remove body organs (Nemathaga et al., 2008; Jang et al., 2006; 
Oweis et al., 2005; WHO, 2000). Clinical waste can be categorized as infectious waste, 
radioactive waste, chemical waste, pathological waste, pharmaceutical waste and sharps 
(Pruss et al., 1999). Examples of different types of clinical solid waste are given in Table 
2.2 (Lee et al., 2002; Nemathaga et al., 2008; Shinee et al., 2008).  
 
Table 2.2 Examples of types of Clinical solid waste 
Category Examples 
Infectious waste  Lab cultures and stocks of infectious agents, wastes from 
isolation wards, tissues, materials or equipment contact with 
infected patients  
Pharmaceutical waste  Expired or unnecessary pharmaceuticals and drugs. 
Pathological waste  Body parts, human fetuses, blood, other body fluids.  
Chemical waste  Solid chemicals from diagnostic and experimental work, 
cleaning materials,  
Radioactive waste  Radioactive substances from radiotherapy or lab work  
Sharps Needles, syringes, blades, broken glass, scalpels etc. 
 
 
The ministry of Health of Malaysia categorises the healthcare waste in the 
guideline as general waste and special regulated waste (MOH, 2009). The clinical waste 
is a one of the sub categories of the regulated waste. The clinical waste has been defined 
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as scheduled waste under the Environmental Quality Regulations, 1989 and further 
classified as infectious, pathological and sharp waste (MOH, 2009). According the 
MOH, (2009), the classification of healthcare waste is presented in Figure 2.1. Clinical 
waste is defined by MOH, (2009) as: 
 
 
a. Any waste which consists  entirely or partly of human or animal tissue, blood or 
other body fluids, excretions, drugs or other pharmaceutical products, swabs or 
dressings or syringes, needles or other sharp instruments, being waste which 
unless rendered safe may prove hazardous to persons coming into contact with it; 
and  
 
b. Any other waste arising from medical, nursing, dental, veterinary, 
pharmaceutical or similar practice, investigation, treatment, care, teaching or 
research or the collection of blood from transfusion, being waste which may 
cause infection to any person coming into contact with it. 
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Figure 2.1 The classification of healthcare waste (Source: MOH, 2009). 
 
 
2.3 Source of clinical solid waste 
 
The principal sources of clinical solid waste are hospitals and clinics, particularly 
those providing acute services, i.e, offering Operating theatres, Maternity ward, 
Accident & Emergency, Mortuary, Intensive Care, Isolation Wards, Pharmacy, 
Pathology Laboratories and other research facilities (Bendjoudi et al., 2009; Blenkharn, 
1995; Da Silva et al., 2005; Marinkovic et al., 2008). Other sources of clinical waste are 
ambulance services, public health laboratories, blood donation centers and blood banks, 
practice center of doctors, dentists, veterinary surgeons, immunization/vaccination 
clinics and hospitals, clinics and nursing homes providing community care, care of the 
elderly and services related to mental health and learning disabilities (Hagen et al., 2001; 
Marinkovic et al., 2008; Pruss et al., 1999).  
Infectious Pathological
waste 
Sharp 
Helthcare waste 
Regulated waste General waste 
Radioactive 
 
Chemical Pharmaceutical 
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There has been an increase in the amount of clinical waste coming from 
households. This is due in part to changes in health care policies. The establishment of 
home health and medical care services has, in recent years, become a basic requirement 
for the population (Blenkharn, 2008; Slack et al., 2004). Both medical devices and 
instruments are used while treating patients at home, thereby producing a variety of 
waste materials. Self-injecting diabetics and people changing colostomy bags at home 
can also generate significant quantities of clinical waste (Blenkharn, 2008; Harsh et al., 
2010). The wastes generated from the treatment of patients suffering from infectious 
diseases may spread infection either through direct contact or indirectly through the 
environment. Waste materials originating from home health and medical care services 
are still included in general household waste materials, even when the wastes are 
infectious (Blenkharn, 2008; Miyazaki et al., 2007). However, the management of 
household infectious waste material has not received any attention yet, even in a 
developed country like Japan (Miyazaki et al., 2007). 
 
 
2.4 Clinical solid waste generation 
 
Generally, healthcare waste generation rate depends on the type of healthcare 
establishment, availability of instrumentations, general condition of HCFs area, ratio of 
disposable item in use and number of patient care (Alagoz and Kocasoy, 2008; Bdour et 
al., 2007; Cheng et al., 2009; Mohee, 2005). Also, the economic, social and cultural 
status of the patients might change the amount of waste generation (Askarian et al., 
2004; Hassan et al., 2008). Among the factors, the number of day-care patients has a 
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significant effect on waste generation rate (Bdour et al., 2007; Patwary et al., 2009a). 
For example, Bdour et al. (2007) and Patwary et al. (2009a) reported that, due to the 
higher number of day-care patients, public healthcare facilities produce larger amount of 
healthcare waste than private healthcare facilities.  
 
 
The proportion of clinical waste per bed is similar in both public and private 
hospitals because of the mismanagement of HCW and a lack of segregation of waste for 
sorting the clinical waste in surveying hospitals (Patwary et al., 2009a). Marinkovic et 
al., (2008) reported that the healthcare waste generation rate depends on the size and the 
type of the medical institution, which might differ from country to country based on the 
level of the economic development (Nemathaga et al, 2008). The developed countries 
generate higher amounts of healthcare waste than that of the developing countries 
(Marinkovic et al., 2008, Nemathaga et al, 2008, Pruss et al., 1999). Data from World 
Health Organization reveals that North America produces 7-10 kg of healthcare waste 
per bed/day, whereas South America produces 3 kg of waste per bed/day. This 
difference was also found in Europe and Asia. Western Europe produces 3-6 kg, 
whereas Eastern Europe 1.4-2 kg of waste per bed/day. In Asia, richer countries produce 
2.5 kg per bed/day, and poorer countries 1.8-2 kg per bed/day (Pruss et al., 1999). From 
the data, it was evident that amount of healthcare waste generation rate depends on the 
level of economic development of the region. It was also noticed that, due to a higher 
level of economic development, the North America produces the largest amount of 
waste. This is might be due to the developed nation’s lifestyle demands consumption of 
a high amount of goods and services, which tends to generate a higher amount of waste 
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(Marinkovic et al., 2008). Furthermore, the use of disposable instruments and packaging 
materials rather than the use of reusable items in healthcare centers in developed 
countries might increase the amount waste generation. 
 
 
The clinical waste generation rate depends on waste management plan and 
segregation activities (Alagoz and Kocasoy, 2008). Cheng et al., (2009) reported that the 
total amount of healthcare waste generation is much higher at medical centers and 
private hospitals, but the proportion of clinical waste is much higher at local hospitals. 
This is due to poor segregation practice followed during sorting the clinical waste in the 
local hospital, which contaminated the non-clinical waste, hence the amount of clinical 
waste generation increased. The contribution of clinical wastes to the total waste stream 
varied from about 12.5–69.3% (Abd El-Salam, 2010; Da Silva et al., 2005; Hassan et al., 
2008; Nemathaga et al., 2008; Sawalem et al., 2009; Shinee et al., 2008).  The healthcare 
waste generation rate in different countries is given in Table 2.3. It is evident from the 
Table 2.3, developing countries in Africa (South Africa, Algeria, Egypt, Libya) and Asia 
(Bangladesh, Mongolia) continent generate the lower amount of HCW, but the 
proportion of clinical waste among total waste higher than that of middle develop 
countries in Europe continent (Croatia, Greece).  This is because, the developed nations 
are following advanced legislation and guidelines during waste collection, and state of 
various possible ways during waste handling, storage and transportation to minimize the 
clinical waste generated (Alagoz and Kocasoy, 2008; Almuneef and Memish, 2003; 
Tudor, 2007). Clinical waste has not yet fully appreciated in the developing countries, 
still handled and disposed together with non-clinical waste (Alagoz and Kocasoy, 2008). 
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Though, in the beginning, minor proportion of the total waste may be considered as 
clinical waste. Later, cross-contamination might occur due to mixing with the non-
clinical waste, which is rendering the entire load of clinical waste (Blenkharn, 1995; 
Patwary et al., 2009a, b).  
 
 
Quantity and quality of clinical waste generated at its source are the key issues to 
decide an effective clinical waste management practice (Coker et al., 2009; Shinee et al., 
2008). Therefore, it is important to minimize clinical waste generation rate at generation 
source. Appropriate segregation and sorting of clinical waste at source can minimize the 
clinical solid waste generation rate.  One of the critical obstacles to conduct source 
segregation of clinical solid waste is lack of knowledge on risk exposure of clinical solid 
waste.  
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Table 2.3 Average health care waste generation rate in different countries hospitals 
Country/City Waste generation rate 
 
Non- 
clinical 
waste, 
% 
Clinical 
waste, 
% 
Generation period Number 
of 
samples 
Region Reference 
Algeria 0.7-1.22 kg/bed/day 75-90 10-25 16 September to 10 
October, 2006 
10 Africa Bendjoudi et al., 2009 
Libya 1.3 kg/patient/day 72 26  14 Africa Sawalem et al., 2009 
South Africa 0.60 kg/patient/day 60.74 39.26 April and July, 2003 2 Africa Nemathaga et al., 
2008 
Taiwan 2.41-3.26 kg/bed/day N/A N/A N/A 150 Asia Cheng et., 2009 
Brazil 2.63 kg/bed/day 80-85 15-20 September 2001 to March 
2002 
N/A South 
America 
Da Silva et al., 2005 
Jordan 6.10 kg/patient/day* 
 
N/A N/A March to September, 2004 14 Asia Bdour et al., 2009 
Ulaanbaatar, 
Mongolia 
1.4-3.0 kg/patient/day 70.67 29.43 January and February 
2005 
56 Asia Shinee et al., 2008 
Dhaka, 
Bangladesh 
1.71 kg/bed/day 79 21 Over 5 months in 2006 69 Asia Patwary et al., 2009a 
Croatia 2.4 kg per capita 86 14 N/A 151 Europe Marinkovic et al., 
2008 
El-Beheira 
Governorate, 
Egypt 
2.07 kg/bed/day 60.10 38.9 6 month period in 2008 8 Africa Abd El-Salam, 2010 
Sylhet city 
Bangladesh 
0.934 kg/bed/day 63.97 36.03* July 2003 to June 2004 17 Asia Kaisar Alam Sarkar, et 
al., 2006 
Binzhou, China 1.22 kg/bed/day N/A N/A December 2006  to 
January 2007 
6 Asia Ruoyan et al., 2010 
Greece 8.4 kg/bed/day 83.33 16.67 N/A N/A Europe Tsakona et al., 2007 
* Maximum generation rate cited in literature; N/A: Data is not available 
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2.5 Risks of Clinical solid waste 
 
The potential microbiological risks associated with the clinical waste are 
unfamiliar to healthcare workers. This is because of the literature on the role of 
infectious clinical waste as a reservoir of diseases is extremely limited (Salkin, 2003). 
Although, there have been a few reports documented on the infectious risks on clinical 
waste management, but, unfortunately scientifically substantiated evidence of the actual 
content of microorganisms, survival of microorganisms in clinical waste and the 
infectious risks to healthcare workers and the general public are extremely rare. 
Furthermore, the available information is restricted to developing countries, and 
therefore does not reflect the exposure, practices, and risk situations in developing 
countries (Salkin, 2003).  
 
 
The infectious risk posed by clinical solid waste to human health and 
environment, which needs to be assessed, is the potential presence of pathogenic 
microorganisms. A great variety of pathogenic microorganisms  may present in clinical 
solid waste (EA, 2003; Patwary et al., 2012; Pruss et al., 1999; Saini et al., 2004).  A 
person involved in the treatment of clinical waste might be exposed to infectious agents 
through several routes including skin penetration, skin contact, or by the aerogenic route 
(EA, 2003; Pruss et al., 1999).  According to Pruss et al., (1999), the possible 
microorganisms and their infected routes in the human body are given in Table 2.4.   
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Table 2.4 The possible microorganisms and the infected routes in the human body 
 (Source: Pruss et al., (1999)) 
 
Type of infection Transmission vehicles Example of causative organisms 
Gastroentic 
infections 
Faeces and/or vomit Enterobecteria, e.g. Salmonella, 
Shigella spp, Vibrio cholera, 
Helminths 
Respiratory 
infections 
Inhaled secretions, 
saliva 
Mycobacterium tuberculosis, 
measles virus, Streptococcus 
pneumonia 
Ocular infection Eye secretions Herpesvirus 
Genital infections Genital secretions Neisseria gonorrhoeae; 
herpesvirus 
Skin infections Pus Streptococcus spp. 
Anthrax Skin secretions Bacillus anthracis 
Meningitis Cerebro-spinal fluid Neisseria meningitidis 
Acquired 
immunodeficiency 
syndrome (AIDS) 
Blood,sexual 
secretions 
Human immunodeficiency virus 
(HIV) 
 
Haemorrhagic 
fevers 
All bloody products 
and secretions 
Junin, Lassa, Ebola, and Marburg 
viruses 
Septicaemia Blood Staphylococcus spp 
Bacteraemia Blood Coagulase-negative 
Staphylococcus spp.; 
Staphylococcus aureus; 
Enterobacter, Enterococcus, 
Klebsiella, and Streptococcus spp. 
Candidaemia Blood Candida albicans 
Viral hepatitis A Faeces Hepatitis A virus 
Viral hepatitis B 
and C 
Blood and body fluids Hepatitis B and C viruses 
 
